[1] G. Reich, "Near-infrared spectroscopy and imaging: Basic principles and pharmaceutical applications," Adv. Drug Deliv. Rev. 57, 1109–1143 (2005).

[2] G. P. Sabin, M. C. Breitkreitz, A. M. de Souza, P. da Fonseca, L. Calefe, M. Moffa, R. J. Poppi. "Analysis of pharmaceutical pellets: An approach using near-infrared chemical imaging," Anal. Chim. Acta 706, 113–119 (2011).

[3] D. C. Hinz, "Process analytical technologies in the pharmaceutical industry: The FDA's PAT initiative," Anal. Bioanal. Chem. 384, 1036–1042 (2006).

[4] A. S. El-Hagrasy, H. R. Morris, F. D'Amico, R. A. Lodder, J. K. 3 rd. Drennen, "Near-infrared spectroscopy and imaging for the monitoring of powder blend homogeneity," J. Pharm. Sci. 90, 1298–1307 (2001).

[5] H. Ma, C. A. Anderson, "Characterization of pharmaceutical powder blends by NIR chemical imaging," J. Pharm. Sci. 97, 3305–3320 (2008).

[6] T. Furukawa, H. Sato, H. Shinzawa, I. Noda, S. Ochiai, "Evaluation of homogeneity of binary blends of poly (3-hydroxybutyrate) and poly (L-lactic acid) studied by near infrared chemical imaging (NIRCI)," Mater. Charact. 23, 871–876 (2007).

[7] Z. S. Wu, O. Tao, X. X. Dai, M. Du, X. Y. Shi, Y. J. Qiao, "Monitoring of a pharmaceutical blending process using near infrared chemical imaging," Vib. Spectrosc. 63, 371–379 (2012).

[8] L. W. Zhou, Z. S. Wu, X. Y. Shi, M. F. Xu, X. N. Liu, B. Xu, Y. J. Qiao, "Rapid discrimination of chlorpheniramine maleate and assessment of its surface content uniformity in a pharmaceutical formulation by NIR-CI coupled with statistical measurement," J. Spectrosc. 2014 (2014).

[9] A. Palou, J. Cruz, M. Blanco, J. Tomàs, J. de los. Ríos, M. Alcalà, "Determination of drug, excipients and coating distribution in pharmaceutical tablets using NIR-CI," J. Pharm. 2, 90–97 (2012).

[10] O. Y. Rodionova, L. P. Houmoller, A. L. Pomerantsev, P. Geladi, J. Burger, V. L. Dorofeyev, A. P. Arzamastsev. "NIR spectrometry for counterfeit drug detection: A feasibility study," Anal. Chim. Acta 549, 151–158 (2005).

[11] J. Dubois, J. C. Wolff, J. K. Warrack, J. Schoppelrei, E. N. Lewis, "NIR chemical imaging for counterfeit pharmaceutical products analysis," Spectroscopy 22, 40 (2007).

[12] M. B. Lopes, J. C. Wolff, "Investigation into classi fication/sourcing of suspect counterfeit Heptodin (TM) tablets by near infrared chemical imaging," Anal. Chim. Acta 633, 149–155 (2009).

[13] A. A. Gowen, C. P. O'Donnell, P. J. Cullen, S. E. J. Bell, "Recent applications of chemical imaging to pharmaceutical process monitoring and quality control," Eur. J. Pharm. Biopharm. 69, 10–22 (2008).

[14] C. Gendrin, "Chemical imaging and chemometrics for the analysis of pharmaceutical solid dosage forms," Engineering Sciences (Physics), Universite Louis Pasteur-Strasbourg I (2008).

[15] J. Huang, H. Wium, K. B. Qvist, K. H. Esbensen, "Multi-way methods in image analysis—relationships and applications," Chemometr. Intell. Lab. 66, 141–158 (2003).

[16] J. Kirkegaard, C. Secher, N. Mygind, "Effect of the H1 antihistamine chlorpheniramine maleate on histamine — Induced symptoms in the human Conjunctiva," Allergy 37, 203–208 (1982).

[17] J. M. Amigo, J. Cruz, M. Bautista, S. Maspoch, J. Coello, M. Blanco, "Study of pharmaceutical samples by NIR chemical image and multivariate analysis," TrAC. Trend. Anal. Chem. 27, 696–713 (2008).

[18] C. Ravn, E. Skibsted, R. Bro, "Near-infrared chemical imaging (NIR-CI) on pharmaceutical solid dosage forms — Comparing common calibration approaches," J. Pharm. Biomed. 48, 554–561 (2008).

[19] P. Y. Sacre, P. Lebrun, P. F. Chavez, C. D. Bleye, L. Netchacovitch, E. Rozet, R. Klinkenberg, B. Streel, P. Hubert, E. Ziemons, "A new criterion to assess distributional homogeneity in hyperspectral images of solid pharmaceutical dosage forms," Anal. Chim. Acta 818, 7–14 (2014).

[20] M. F. Ferr o, M. D. S. Viera, R. E. P. Pazos, D. Fachini, A. E. Gerbase, L. Marder, "Simultaneous determination of quality parameters of biodiesel/ diesel blends using HATR-FTIR spectra and PLS, iPLS or siPLS regressions," Fuel 90, 701–706 (2011).